Literature DB >> 34373092

Molecular Pathology of Urothelial Carcinoma.

Hikmat Al-Ahmadie1, George J Netto2.   

Abstract

Urothelial carcinoma is characterized by the presence of a wide spectrum of histopathologic features and molecular alterations that contribute to its morphologic and genomic heterogeneity. It typically harbors high rates of somatic mutations with considerable genomic and transcriptional complexity and heterogeneity that is reflective of its varied histomorphologic and clinical features. This review provides an update on the recent advances in the molecular characterization and novel molecular taxonomy of urothelial carcinoma and variant histologies.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular classification; Molecular pathology; Urothelial carcinoma

Mesh:

Year:  2021        PMID: 34373092      PMCID: PMC9175507          DOI: 10.1016/j.path.2021.05.005

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  87 in total

1.  Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Authors:  Hikmat A Al-Ahmadie; Gopa Iyer; Byron H Lee; Sasinya N Scott; Rohit Mehra; Aditya Bagrodia; Emmet J Jordan; Sizhi Paul Gao; Ricardo Ramirez; Eugene K Cha; Neil B Desai; Emily C Zabor; Irina Ostrovnaya; Anuradha Gopalan; Ying-Bei Chen; Samson W Fine; Satish K Tickoo; Anupama Gandhi; Joseph Hreiki; Agnès Viale; Maria E Arcila; Guido Dalbagni; Jonathan E Rosenberg; Bernard H Bochner; Dean F Bajorin; Michael F Berger; Victor E Reuter; Barry S Taylor; David B Solit
Journal:  Nat Genet       Date:  2016-02-22       Impact factor: 38.330

2.  Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.

Authors:  Sumanta K Pal; Jonathan E Rosenberg; Jean H Hoffman-Censits; Raanan Berger; David I Quinn; Matthew D Galsky; Juergen Wolf; Christian Dittrich; Bhumsuk Keam; Jean-Pierre Delord; Jan H M Schellens; Gwenaelle Gravis; Jacques Medioni; Pablo Maroto; Virote Sriuranpong; Chaiyut Charoentum; Howard A Burris; Viktor Grünwald; Daniel Petrylak; Ulka Vaishampayan; Eliahu Gez; Ugo De Giorgi; Jae-Lyun Lee; Jens Voortman; Sumati Gupta; Sunil Sharma; Amir Mortazavi; David J Vaughn; Randi Isaacs; Katie Parker; Xueying Chen; Kun Yu; Dale Porter; Diana Graus Porta; Dean F Bajorin
Journal:  Cancer Discov       Date:  2018-05-30       Impact factor: 39.397

3.  Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.

Authors:  Charles Chuanhai Guo; Vipulkumar Dadhania; Li Zhang; Tadeusz Majewski; Jolanta Bondaruk; Maciej Sykulski; Weronika Wronowska; Anna Gambin; Yan Wang; Shizhen Zhang; Enrique Fuentes-Mattei; Ashish Madhav Kamat; Colin Dinney; Arlene Siefker-Radtke; Woonyoung Choi; Keith A Baggerly; David McConkey; John N Weinstein; Bogdan Czerniak
Journal:  Eur Urol       Date:  2016-03-15       Impact factor: 20.096

4.  Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma.

Authors:  Mathilde B H Thomsen; Iver Nordentoft; Philippe Lamy; Søren Høyer; Søren Vang; Jakob Hedegaard; Michael Borre; Jørgen B Jensen; Torben F Ørntoft; Lars Dyrskjøt
Journal:  Mol Oncol       Date:  2016-08-17       Impact factor: 6.603

Review 5.  Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications.

Authors:  Mahul B Amin
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

6.  A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.

Authors:  Jeffrey S Ross; Kai Wang; Laurie M Gay; Rami N Al-Rohil; Tipu Nazeer; Christine E Sheehan; Timothy A Jennings; Geoff A Otto; Amy Donahue; Jie He; Gary Palmer; Siraj Ali; Michelle Nahas; Geneva Young; Elaine Labrecque; Garrett Frampton; Rachel Erlich; John A Curran; Kristina Brennan; Sean R Downing; Roman Yelensky; Doron Lipson; Matthew Hawryluk; Vincent A Miller; Philip J Stephens
Journal:  Clin Cancer Res       Date:  2013-11-05       Impact factor: 12.531

7.  Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.

Authors:  Sumit Isharwal; Hongying Huang; Gouri Nanjangud; François Audenet; Ying-Bei Chen; Anuradha Gopalan; Samson W Fine; Satish K Tickoo; Byron H Lee; Gopa Iyer; Kalyani Chadalavada; Jonathan E Rosenberg; Dean F Bajorin; Harry W Herr; S Machele Donat; Guido Dalbagni; Bernard H Bochner; David B Solit; Victor E Reuter; Hikmat A Al-Ahmadie
Journal:  Hum Pathol       Date:  2018-03-27       Impact factor: 3.466

8.  Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care.

Authors:  Alexander Penson; Niedzica Camacho; Youyun Zheng; Anna M Varghese; Hikmat Al-Ahmadie; Pedram Razavi; Sarat Chandarlapaty; Christina E Vallejo; Efsevia Vakiani; Teresa Gilewski; Jonathan E Rosenberg; Maha Shady; Dana W Y Tsui; Dalicia N Reales; Adam Abeshouse; Aijazuddin Syed; Ahmet Zehir; Nikolaus Schultz; Marc Ladanyi; David B Solit; David S Klimstra; David M Hyman; Barry S Taylor; Michael F Berger
Journal:  JAMA Oncol       Date:  2020-01-01       Impact factor: 31.777

9.  Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.

Authors:  Gottfrid Sjödahl; Pontus Eriksson; Fredrik Liedberg; Mattias Höglund
Journal:  J Pathol       Date:  2017-03-28       Impact factor: 7.996

10.  Comparative genomic profiling of glandular bladder tumours.

Authors:  Angela Maurer; Nadina Ortiz-Bruechle; Karolina Guricova; Michael Rose; Ronja Morsch; Stefan Garczyk; Robert Stöhr; Simone Bertz; Reinhard Golz; Henning Reis; Felix Bremmer; Annette Zimpfer; Sabine Siegert; Glen Kristiansen; Kristina Schwamborn; Nikolaus Gassler; Ruth Knuechel; Nadine T Gaisa
Journal:  Virchows Arch       Date:  2020-03-20       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.